πΊπΈ FDA Control of Nitrosamine Impurities in Human Drugs revision2
|
|
23
|
1439
|
October 13, 2024
|
π
Updates on Approaches to Acceptable Intakes of Nitrosamine Drug Substance Related Impurities (NDSRIs) and Bioequivalence Assessment for Reformulated Drug Products(CRCG)
|
|
5
|
883
|
October 9, 2024
|
π²π½ Mexico Nitrosamine Guide published today
|
|
22
|
1844
|
September 24, 2024
|
Become a USP Expert Volunteer
|
|
1
|
328
|
September 19, 2024
|
π¨βπ» Dashboard Containing Published AI Limits
|
|
32
|
3310
|
August 2, 2024
|
Quantification of Nitrite in Excipients and Chemicals: A Versatile and Highly Sensitive Method Using Headspace Gas Chromatography Coupled to Mass Spectrometry -Pub
|
|
0
|
1028
|
July 23, 2024
|
Modeling the Impact of Excipients Selection on Nitrosamine Formation towards Risk Mitigation
|
|
16
|
3234
|
June 8, 2024
|
Risk Assessment Study of Nitrosamines for the API Temozolomide Industrial Process -Pub
|
|
1
|
1844
|
February 6, 2024
|